Literature DB >> 24523454

CMV infection and glioma, a highly controversial concept struggling in the clinical arena.

Wolfgang Wick1, Michael Platten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24523454      PMCID： PMC3922527          DOI： 10.1093/neuonc/nou002

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  18 in total

1.  Consensus on the role of human cytomegalovirus in glioblastoma.

Authors:  Kristine Dziurzynski; Susan M Chang; Amy B Heimberger; Robert F Kalejta; Stuart R McGregor Dallas; Martine Smit; Liliana Soroceanu; Charles S Cobbs
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

2.  Immortal time bias in retrospective analysis: is there a survival benefit in patients with glioblastoma who received prolonged treatment of adjuvant valganciclovir?

Authors:  Chia-Jen Liu; Yu-Wen Hu
Journal:  Int J Cancer       Date:  2014-01-06       Impact factor: 7.396

Review 3.  Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.

Authors:  Michael J Cannon; D Scott Schmid; Terri B Hyde
Journal:  Rev Med Virol       Date:  2010-07       Impact factor: 6.989

Review 4.  Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells.

Authors:  J Cinatl; J Cinatl; J U Vogel; H Rabenau; B Kornhuber; H W Doerr
Journal:  Intervirology       Date:  1996       Impact factor: 1.763

5.  Lack of association of cytomegalovirus with human brain tumors.

Authors:  Sean K Lau; Yuan-Yuan Chen; Wen-Gang Chen; Don J Diamond; Adam N Mamelak; John A Zaia; Lawrence M Weiss
Journal:  Mod Pathol       Date:  2005-06       Impact factor: 7.842

6.  Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations.

Authors:  Richard L Price; Jieun Song; Katherine Bingmer; Tae Hyong Kim; Ji-Yeun Yi; Michal O Nowicki; Xiaokui Mo; Todd Hollon; Eric Murnan; Christopher Alvarez-Breckenridge; Soledad Fernandez; Balveen Kaur; Andreana Rivera; Michael Oglesbee; Charles Cook; E Antonio Chiocca; Chang-Hyuk Kwon
Journal:  Cancer Res       Date:  2013-06-01       Impact factor: 12.701

7.  Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity.

Authors:  Charles S Cobbs; Liliana Soroceanu; Scott Denham; Wenyue Zhang; Matthias H Kraus
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

8.  Human cytomegalovirus infection and expression in human malignant glioma.

Authors:  Charles S Cobbs; Lualhati Harkins; Minu Samanta; G Yancey Gillespie; Suman Bharara; Peter H King; L Burt Nabors; C Glenn Cobbs; William J Britt
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

9.  Detection of human cytomegalovirus genome and gene products in central nervous system tumours.

Authors:  J Sabatier; E Uro-Coste; I Pommepuy; F Labrousse; S Allart; M Trémoulet; M B Delisle; P Brousset
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

Review 10.  Human cytomegalovirus: Latency and reactivation in the myeloid lineage.

Authors:  John Sinclair
Journal:  J Clin Virol       Date:  2008-03       Impact factor: 3.168
View more
  12 in total

1.  Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India.

Authors:  Ravindra Pramod Deshpande; Deepak Babu; Manas Panigrahi; Y B V K Chandra Sekhar; Phanithi Prakash Babu
Journal:  J Neurooncol       Date:  2016-06-16       Impact factor: 4.130

Review 2.  Prioritization schema for immunotherapy clinical trials in glioblastoma.

Authors:  Tiffany R Hodges; Sherise D Ferguson; Hillary G Caruso; Gary Kohanbash; Shouhao Zhou; Timothy F Cloughesy; Mitchel S Berger; George H Poste; Mustafa Khasraw; Sujuan Ba; Tao Jiang; Tom Mikkelson; W K Alfred Yung; John F de Groot; Howard Fine; Lewis C Cantley; Ingo K Mellinghoff; Duane A Mitchell; Hideho Okada; Amy B Heimberger
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

Review 3.  Cytomegalovirus and glioblastoma; controversies and opportunities.

Authors:  Sean E Lawler
Journal:  J Neurooncol       Date:  2015-02-15       Impact factor: 4.130

4.  Lack of human cytomegalovirus expression in single cells from glioblastoma tumors and cell lines.

Authors:  Travis S Johnson; Zachary B Abrams; Xiaokui Mo; Yan Zhang; Kun Huang
Journal:  J Neurovirol       Date:  2017-07-10       Impact factor: 2.643

5.  Modeling cytomegalovirus infection in mouse tumor models.

Authors:  Richard Lee Price; Ennio Antonio Chiocca
Journal:  Front Oncol       Date:  2015-03-17       Impact factor: 6.244

6.  The future of high-grade glioma: Where we are and where are we going.

Authors:  Emilie Le Rhun; Emilie Le Rhun; Sophie Taillibert; Marc C Chamberlain
Journal:  Surg Neurol Int       Date:  2015-02-13

7.  A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association.

Authors:  Michael J Strong; Eugene Blanchard; Zhen Lin; Cindy A Morris; Melody Baddoo; Christopher M Taylor; Marcus L Ware; Erik K Flemington
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

8.  Microbial infection, inflammation and epithelial ovarian cancer.

Authors:  Xiaohui Xie; Mengyuan Yang; Yiling Ding; Jianlin Chen
Journal:  Oncol Lett       Date:  2017-06-15       Impact factor: 2.967

9.  Epstein-Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer.

Authors:  Zhenjiang Liu; Thomas Poiret; Qingda Meng; Martin Rao; Anna von Landenberg; Esther Schoutrop; Davide Valentini; Ernest Dodoo; Inti Peredo-Harvey; Markus Maeurer
Journal:  J Transl Med       Date:  2018-07-03       Impact factor: 5.531

10.  Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls.

Authors:  Cheng-Te Major Lin; Emily C Leibovitch; M Isabel Almira-Suarez; Steven Jacobson
Journal:  Infect Agent Cancer       Date:  2016-07-26       Impact factor: 2.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.